The protocol of the experiment was designed as follows. In the morning, the instrument was prepared for operation by calibration and verification with whole blood gas control samples (Quantra; Dade Division of American Hospital Supply Corp., Miami, FL 33152). An IL blood gas control, ContrIL, was analyzed for P02 before and after the determination on blood from the patient in surgery. Two levels of IL blood gas controls (Normal ContrlL and Alkalosis ContrlL) were used in this study and the reproducibility of each was determined. The mean value for 18 results for Normal ContrlL was 96.3 mrnHg (SD 0.93),with a CV of 1%.The mean value for 19 results for Alkalosis ContrlL was 146.3 (SD 0.96) mmHg, with a CV of 0.7%. Table 1 shows the analytical results for 25 paired (before and after) control samples from seven patients.
We did 18 single analyses on control samples immediately after blood samples containing various levels of halothane. All data inTable 1 were obtained by using a single p02 electrode. The results demonstrate that there was no significant halothane carryover effect with the P02 electrode in the IL 813 blood gas analyzer. 
Comparison of Radioimmunoassay Results in Serum and Plasma

To the Editor:
In recent reports Kubasik and Sine have compared serum and plasma results for a total of 25 analytes in 31 different radioassay procedures (1, 2).
They found statistically significant differences, some of substantial magnitude, between sample types for many of these procedures. No apparent predictor exists regarding which assays will be affectedby sample type: each kit or reagent system must be evaluated separately. Here, I report results for serum and for plasma treated with ethylenediaminetetraacetate (EDTA) or heparin, as determined in 12 radioimmunoassay (RIA) procedures in our laboratory.
I evaluated the following kits and component systems using the manufacturer's suggested protocols: Progesterone: "Progesterone radio-
immunoassay kit"; CIS Radiopharmaceuticals.
Prolactin:
"Prolactin radioimmunoassay kit"; CIS Radiopharmaceuticals. Testosterone (antisera and tritiated steriod): Radioassay Systems Laboratories, Inc., Carson, CA 90746; standard from Sigma Chemical Co.
Thyrotropin: "Quantitope 125 IThyroid-stimulating hormone radioimmunoassay kit"; Kallestad Labs.
Supernates of the tritiated steroid assays (estradiol, estrone, progesterone, and testosterone) were decanted into 10 mL of Biocount (Research Products International, Elk Grove, IL 60007) scintillation cocktail and counted with a Tri-Carb Liquid Scintillation System (Model 2425; Packard Instrument Co., Downers Grove, IL 60515). The remaining assays, which involved 1251, were counted with a Packard AutoGamma Scintillation Counter (Model 5360).
I used a Hewlett-Packard 9810 desktop calculator and a weighted leastsquares regression of a logit-log plot to evaluate the radioimmunoassay data Plasma samples were immediately separated from the cells in a refrigerated centrifuge (3000 X g, 10 mm, 4 #{176}C). Serum samples were allowed to clot at 4 #{176}C, then separated in the same centrifuge. Plasmas and sera were aliquoted and frozen immediately after centrifugation. One heparin-containing tube was broken, so that n = 12 for heparintreated plasma and 13 for EDTAtreated plasma and for serum.
All subjects were in good health. Blood samples were obtained between 0800 and 1000 h, after an overnight fast.
Hormonal
and cycle-day data indicate that five of the women were in the follicular phase of their menstrual cycles, two in the luteal stage, and one postmenopausal. None were taking oral contraceptivesor other hormonal medication.
Because In sixof the 11 procedures shown in Table 1 , the differences in results were statistically significant between the two sample types: mean assayed values were lower for EDTA-treated plasma than for serum. The decrease was small in most cases, but could be clinically relevant in a borderline abnormal sample. The apparently normal volunteers in this study provided samples for analysis over a wide range of values for the reproductive hormones.
For such analytes as somatotropin and thyrotropin, however, all values fell well within the normal range. I do not know whether a sample with above-normal concentrations of these hormones would show proportionally greater or lesser discrepancy between serum and EDTA-treated plasma.
The comparison of results from serum with those from heparin-treated plasma in all assays except corticotropin showed no statistically significant differences (see Table 2 ).
In the assay for corticotropin, serum values (17.0 ng/L, SD 28.5 ng/L) are significantlyless (p <0.01, n = 13) than those in EDTA-treated plasma (29.0 ng/L, SD 28.3 ng/L), the specimen of choice. This is because of the lability of corticotropin in the presence of eryth- 
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Test and Units Masursd (1, 2) , emphasize the need to evaluate separately for each procedure or kit in use the effects of serum and variously anticoagulated plasmas on assayed values.When significant differences exist, the sample of choicemust always correspond to the standards in the kit and to the samples used to calculate expected value ranges.
Although the prime importance of obtaining such data is the prevention of erroneous and misleading results through use of inappropriate samples, it is also valuable to know when different samples can be substituted with impunity. For instance, reference laboratories are not able to directly supervise the collection of specimens sent to them for analysis; physiciansoften callto add furthertestsafter the blood has been drawn; and collection of multiple specimens may be contraindicated in the case of infants or the critically ill. Unnecessarily repeated venipunctures are costly in terms of time, money, and patient inconvenience. 
ErythrocyteProtoporphyrin/Heme Ratioby Hematofluorometry
To the Editor:
A recent report in this journal by Labb#{233} et al. (1) provides additional data to show that the free erythrocyte protoporphyrin (FEP) to heme ratio is a better indicator of a person's iron status than is the whole blood FEP concentration alone, as Piomelli et al. (2) suggested previously. Piomelli (3) also prefers the use of this ratio for lead intoxication screening. In the study by Labb#{233} et al. (1) , the FEP content of blood specimens was measured fluorometrically after extraction, and the heme was measured absorptimetrically as the bispyridine complex. The protocol is convenient and accurate because the heme is determined in the precipitate of the FEP extraction step, and as a consequence the FEP/heme ratio is very "forgiving" ofvariations in specimen volume.
Labb#{233} et al. mention that commercial hematofluorometers can measure the zinc protoporphyrin (ZPP) concentration in blood conveniently. We remind the reader that a front-face fluorometer (hematofluorometer) can accurately provide the porphyrin/heme ratio directly, in one drop of whole blood, within a few seconds (4).
In the "front-face" geometry, the intensity of fluorescence from whole blood excited with light in the range of the
